Celldex Therapeutics Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters Option to Purchase Additional Shares
April 06, 2026 10:53 ET | Source: Celldex Therapeutics, Inc. HAMPTON, N.J.,…
NYSE Content Update: Koppers to Ring Closing Bell for 20th Listing Anniversary
NYSE issues a pre-market daily advisory direct from the trading floor.NEW YORK,…
Onboarding holds the secret to closing the ‘revolving door’ of hiring in US manufacturing, Talogy research finds.
PITTSBURGH, March 24, 2026 /PRNewswire/ -- As US industrial sectors grapple with persistent…
NYSE Content Update: Xylem to Ring Closing Bell Before World Water Day 2026
NYSE issues a pre-market daily advisory direct from the trading floor.NEW YORK,…
![Singapore’s MetaComp Raises Pre-A+ Round Backed By Alibaba, Closing Total US$35 Million Pre-A Funding in 3 months to Accelerate Asia’s Regulated Web2.5 Pay and Wealth[1] Group-Level Platform](https://i0.wp.com/mma.prnewswire.com/media/2933162/Second_funding_months_brings_total_raised_US_35_million_stablecoin_related_infrastructure.jpg?p=thumbnail&w=420&resize=420,280&ssl=1 "Singapore’s MetaComp Raises Pre-A+ Round Backed By Alibaba, Closing Total US$35 Million Pre-A Funding in 3 months to Accelerate Asia’s Regulated Web2.5 Pay and Wealth[1] Group-Level Platform")
Singapore’s MetaComp Raises Pre-A+ Round Backed By Alibaba, Closing Total US$35 Million Pre-A Funding in 3 months to Accelerate Asia’s Regulated Web2.5 Pay and Wealth[1] Group-Level Platform
SINGAPORE, March 13, 2026 /PRNewswire/ -- MetaComp Pte. Ltd, Asia's pioneer in…
AIM ImmunoTech Announces Closing of its Rights Offering
OCALA, Fla., March 06, 2026 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE…
3iQ Announces Successful Closing of Previously Announced Transaction with Coincheck Group N.V.
TORONTO, March 2, 2026 /PRNewswire/ -- 3iQ Corp. ("3iQ"), a global pioneer…
3iQ Announces Earlier Than Anticipated Closing of Previously Disclosed Transaction with Coincheck Group N.V.
TORONTO, Feb. 24, 2026 /PRNewswire/ -- 3iQ Corp. ("3iQ"), a global pioneer…
Eupraxia Pharmaceuticals Announces Closing of US$63.2 Million Public Offering Including Full Exercise of Underwriter Option
February 20, 2026 15:10 ET | Source: Eupraxia Pharmaceuticals Inc. VICTORIA, British…
Ernexa Therapeutics to Participate in Virtual Investor Closing Bell Series
February 20, 2026 09:05 ET | Source: Ernexa Therapeutics Inc. Live video…
